|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.630 USD | -1.63% |
|
-1.49% | -0.30% |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| 05-11 | Evolus Plans to Launch Estyme Collection in Europe | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- EOLS Stock
- Consensus Evolus, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
